Shafran SD et al. |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. |
1996 |
N. Engl. J. Med. |
pmid:8676931
|
Shimoyama T et al. |
Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection. |
1996 |
J. Gastroenterol. |
pmid:8680535
|
MacConnachie AM |
Clarithromycin (klaricid, Abbott). |
1996 |
Intensive Crit Care Nurs |
pmid:8696027
|
Meier A et al. |
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. |
1996 |
J. Infect. Dis. |
pmid:8699066
|
Sellal A et al. |
[Maintenance treatment of cerebral toxoplasmosis in AIDS: role of clarithromycin-minocycline combination]. |
1996 |
Presse Med |
pmid:8685115
|
Schouenborg P |
[Clarithromycin]. |
1996 |
Ugeskr. Laeg. |
pmid:8686028
|
Goddard AF et al. |
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. |
1996 |
Gastroenterology |
pmid:8690200
|
Lambert JR |
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy. |
1996 |
Gastroenterology |
pmid:8690219
|
Gisbert JP et al. |
Response to article by Forné et al. |
1996 |
Am. J. Gastroenterol. |
pmid:8561132
|
Steinman MA and Steinman TI |
Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis. |
1996 |
Am. J. Kidney Dis. |
pmid:8546130
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Wintermeyer SM et al. |
Dirithromycin: a new macrolide. |
1996 |
Ann Pharmacother |
pmid:8893122
|
van der Hulst RW et al. |
Therapeutic options after failed Helicobacter pylori eradication therapy. |
1996 |
Am. J. Gastroenterol. |
pmid:8931413
|
Alder JD et al. |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies. |
1996 |
Am. J. Gastroenterol. |
pmid:8931416
|
Vilmà nyi E et al. |
Clarithromycin pharmacokinetics after oral administration with or without fasting in crossbred beagles. |
1996 |
J Small Anim Pract |
pmid:8934426
|
Yago K et al. |
[Protein binding of clarithromycin in patients with chronic renal failure]. |
1996 |
Jpn J Antibiot |
pmid:8935121
|
Koguchi M et al. |
[Antimicrobial activities of clarithromycin against clinical isolates]. |
1996 |
Jpn J Antibiot |
pmid:8935125
|
Tomioka H et al. |
[Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones]. |
1996 |
Kekkaku |
pmid:8999135
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Aoyama T et al. |
Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. |
1996 |
J. Pediatr. |
pmid:8917247
|
Koeck JL et al. |
Disseminated Mycobacterium simiae infection in a patient with AIDS: clinical features and treatment. |
1996 |
Clin. Infect. Dis. |
pmid:8909856
|
Liviu L et al. |
Pancreatitis induced by clarithromycin. |
1996 |
Ann. Intern. Med. |
pmid:8849171
|
Dammann HG |
[Helicobacter pylori eradication: triple therapy versus dual therapy]. |
1996 |
Fortschr. Med. |
pmid:8852685
|
Cone LA et al. |
Mania due to clarithromycin therapy in a patient who was not infected with human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8853002
|
Yousfi MM et al. |
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8853767
|
Schimkat M et al. |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus. |
1996 |
Ger J Ophthalmol |
pmid:8854102
|
Stone GG et al. |
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. |
1996 |
Helicobacter |
pmid:9432314
|
Hunt RH |
Eradication of Helicobacter pylori infection. |
1996 |
Am. J. Med. |
pmid:8644782
|
Torriani FJ et al. |
Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. |
1996 |
J. Infect. Dis. |
pmid:8603975
|
Vakil N and Fennerty MB |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. |
1996 |
Am. J. Gastroenterol. |
pmid:8607487
|
Treiber G |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. |
1996 |
Am. J. Gastroenterol. |
pmid:8607488
|
Shaheen N and Grimm IS |
Fulminant hepatic failure associated with clarithromycin. |
1996 |
Am. J. Gastroenterol. |
pmid:8607519
|
Horowitz RS et al. |
Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. |
1996 |
Arch. Intern. Med. |
pmid:8607732
|
Dhaenens L et al. |
In-vitro activities of clarithromycin and other antimicrobial agents against Helicobacter pylori isolated from children. |
1996 |
J. Antimicrob. Chemother. |
pmid:8877551
|
Tursi A et al. |
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. |
1996 |
J. Clin. Gastroenterol. |
pmid:8877648
|
Thor P et al. |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. |
1996 |
J. Physiol. Pharmacol. |
pmid:8877902
|
Ji B et al. |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878595
|
Heifets L |
Susceptibility testing of Mycobacterium avium complex isolates. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843278
|
Alper CM et al. |
Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843299
|
Rana KZ et al. |
Clarithromycin does not affect phosphorylation of zidovudine in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843311
|
|
Three new studies expand understanding of MAC therapy. |
1996 |
Am J Health Syst Pharm |
pmid:8899122
|
Yamamoto T et al. |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834892
|
Ji B et al. |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice? |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834894
|
Dattwyler RJ et al. |
Clarithromycin in treatment of early Lyme disease: a pilot study. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834900
|
Versalovic J et al. |
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834903
|
Wallace RJ et al. |
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807061
|
Gillum JG et al. |
Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807068
|
Jaup BK |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin. |
1996 |
Helicobacter |
pmid:9398878
|
Moayyedi P et al. |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. |
1996 |
Helicobacter |
pmid:9398880
|
Mégraud F and Malfertheiner P |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995. |
1996 |
Helicobacter |
pmid:9398889
|
O'Morain C et al. |
Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. |
1996 |
Helicobacter |
pmid:9398893
|
Lind T et al. |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. |
1996 |
Helicobacter |
pmid:9398894
|
van der Hulst RW et al. |
Treatment of Helicobacter pylori infection: a review of the world literature. |
1996 |
Helicobacter |
pmid:9398908
|
|
NIAID study rules out high-dose clarithromycin for AIDS-related MAC. |
1996 |
AIDS Patient Care STDS |
pmid:11361534
|
|
New data suggest antibiotic clarithromycin is effective in prolonging life of AIDS patients. |
1996 |
AIDS Patient Care STDS |
pmid:11361575
|
|
Clarithromycin and MAC. |
1996 |
AIDS Patient Care STDS |
pmid:11361673
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
Sander P et al. |
Ribosomal drug resistance in mycobacteria. |
1996 Jan-Feb |
Res. Microbiol. |
pmid:8761724
|
Papp J et al. |
Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report. |
1996 Jul-Aug |
Br J Clin Pract |
pmid:8794601
|
Tursi A et al. |
One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection. |
1996 Jul-Aug |
Hepatogastroenterology |
pmid:8884304
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Akamatsu H et al. |
Enhanced effect of clarithromycin on neutrophil function in vitro. |
1996 Mar-Apr |
J. Int. Med. Res. |
pmid:8737228
|
Nightingale SL |
From the Food and Drug Administration. |
1996 May 22-29 |
JAMA |
pmid:8622234
|
Prescott LM |
Clarithromycin for MAC prevention offers additional benefits. |
1996 May-Jun |
Posit Aware |
pmid:11363431
|
Mertl SL |
The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. |
1996 May-Jun |
Pharmacotherapy |
pmid:8726597
|
Ono T et al. |
In vitro and in vivo antibacterial activities of clarithromycin. |
1996 May-Jun |
Chemotherapy |
pmid:8983882
|
Peeling RW and Brunham RC |
Chlamydiae as pathogens: new species and new issues. |
1996 Oct-Dec |
Emerging Infect. Dis. |
pmid:8969247
|
Phull PS et al. |
Lansoprazole plus clarithromycin: evaluation of a new dual therapy for Helicobacter pylori eradication. |
1996 Oct-Nov |
Br J Clin Pract |
pmid:9015906
|
Irie Y et al. |
Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301989
|
Stone GG et al. |
PCR-RFLP typing of ureC from Helicobacter pylori isolated from gastric biopsies during a European multi-country clinical trial. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301991
|
Rodvold KA et al. |
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9174209
|
Fujii K et al. |
Multiple primary Mycobacterium avium infection of the skin. |
1997 |
Int. J. Dermatol. |
pmid:9071619
|
Stone GG et al. |
PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin. |
1997 |
Epidemiol. Infect. |
pmid:9129588
|
Tarlow MJ et al. |
Future indications for macrolides. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109159
|
Yanagihara K et al. |
Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. |
1997 |
Am. J. Respir. Crit. Care Med. |
pmid:9001333
|
Martin SJ et al. |
In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9401809
|
Sander P et al. |
The role of ribosomal RNAs in macrolide resistance. |
1997 |
Mol. Microbiol. |
pmid:9402018
|
Brancato R et al. |
Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. |
1997 |
Arch. Ophthalmol. |
pmid:9338681
|
Jingu K et al. |
[A case of fluminant Mycoplasma pneumonia and bronchiolitis managed by artificial respiration]. |
1997 |
Nippon Naika Gakkai Zasshi |
pmid:9340346
|
Yamamoto M et al. |
[The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection]. |
1997 |
Kekkaku |
pmid:9038009
|
Hoppe JE and Tschirner T |
Comparison of Etest and agar dilution for testing the activity of three macrolides against Bordetella parapertussis. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9218920
|
Sugihara J et al. |
[Efficacy of clarithromycin on chronic paranasal sinusitis--a comparison between children and adult]. |
1997 |
Jpn J Antibiot |
pmid:9597431
|
Hamada K et al. |
[Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells]. |
1997 |
Jpn J Antibiot |
pmid:9597434
|
McLaren A et al. |
The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics. |
1997 |
Helicobacter |
pmid:9432317
|
Nilius AM et al. |
Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH. |
1997 |
J. Clin. Microbiol. |
pmid:9163435
|
Bardhan KD et al. |
Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole. |
1997 |
Helicobacter |
pmid:9432318
|
Takimoto T et al. |
The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients. |
1997 |
Helicobacter |
pmid:9432334
|
Moayyedi P |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin? |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9513823
|
Pieramico O et al. |
Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial. |
1997 |
Helicobacter |
pmid:9432335
|
Pounder RE et al. |
Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing. |
1997 |
Helicobacter |
pmid:9432341
|
Bordet AL et al. |
[Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin]. |
1997 |
Ann Dermatol Venereol |
pmid:9686059
|
Laine L et al. |
A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354200
|
Rinaldi V et al. |
The management of failed dual or triple therapy for Helicobacter pylori eradication. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354202
|
Breuer T et al. |
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354204
|
Wurzer H et al. |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354205
|
|
Different clarithromycin doses affect mortality. |
1997 |
AIDS Patient Care STDS |
pmid:11361754
|
Laberge P and Martineau P |
Clarithromycin-induced digoxin intoxication. |
1997 |
Ann Pharmacother |
pmid:9296239
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. |
1997 |
Gut |
pmid:9301496
|